
### [Orphanet:211277](http://www.orpha.net/ORDO/Orphanet_211277)
**Label:** Complex vascular malformation with associated anomalies

**Subclasses:** [Orphanet:163634](http://www.orpha.net/ORDO/Orphanet_163634) (Maffucci syndrome), [Orphanet:168984](http://www.orpha.net/ORDO/Orphanet_168984) (CLAPO syndrome), [Orphanet:2346](http://www.orpha.net/ORDO/Orphanet_2346) (Angioosteohypertrophic syndrome), [Orphanet:109](http://www.orpha.net/ORDO/Orphanet_109) (Bannayan-Riley-Ruvalcaba syndrome), [Orphanet:744](http://www.orpha.net/ORDO/Orphanet_744) (Proteus syndrome), [Orphanet:86914](http://www.orpha.net/ORDO/Orphanet_86914) (Lymphedema-cerebral arteriovenous anomaly syndrome), [Orphanet:140944](http://www.orpha.net/ORDO/Orphanet_140944) (CLOVES syndrome), 

**Corr. equiv. classes:** [OMIM:612918](http://purl.obolibrary.org/obo/OMIM_612918), [Orphanet:86914](http://www.orpha.net/ORDO/Orphanet_86914), [OMIM:153480](http://purl.obolibrary.org/obo/OMIM_153480), [Orphanet:140944](http://www.orpha.net/ORDO/Orphanet_140944), [Orphanet:2346](http://www.orpha.net/ORDO/Orphanet_2346), [OMIM:613089](http://purl.obolibrary.org/obo/OMIM_613089), [OMIM:176920](http://purl.obolibrary.org/obo/OMIM_176920), [OMIM:152900](http://purl.obolibrary.org/obo/OMIM_152900), [OMIM:149000](http://purl.obolibrary.org/obo/OMIM_149000), [OMIM:614569](http://purl.obolibrary.org/obo/OMIM_614569), [Orphanet:163634](http://www.orpha.net/ORDO/Orphanet_163634), [Orphanet:168984](http://www.orpha.net/ORDO/Orphanet_168984), [Orphanet:109](http://www.orpha.net/ORDO/Orphanet_109), [OMIM:608355](http://purl.obolibrary.org/obo/OMIM_608355), [Orphanet:744](http://www.orpha.net/ORDO/Orphanet_744), 

**Class expressions from DL-Learner:**

- [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0003764](http://purl.obolibrary.org/obo/HP_0003764) (Nevus) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0003764](http://purl.obolibrary.org/obo/HP_0003764) (Nevus) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0003764](http://purl.obolibrary.org/obo/HP_0003764) (Nevus) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0003764](http://purl.obolibrary.org/obo/HP_0003764) (Nevus) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0100555](http://purl.obolibrary.org/obo/HP_0100555) (Asymmetric growth) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0100764](http://purl.obolibrary.org/obo/HP_0100764) (Lymphangioma) 63.33%


